Klingman & Associates’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,000
Closed -$328K 170
2021
Q1
$328K Hold
7,000
0.03% 125
2020
Q4
$299K Buy
+7,000
New +$359K 0.03% 122

Other funds holding NRC

Klingman & Associates's NRC Position: Q2 2021 in Review

Klingman & Associates sold out of NRC Health Common Stock (NRC) in Q2 2021, closing a stake of 7,000 shares — an estimated $328K sold.

Klingman & Associates first reported a position in NRC in Q4 2020 and held it in 2 quarters. The position peaked at $328K in Q1 2021. 100 funds tracked by Wall St. Rank hold NRC as of Q2 2021.

  • Klingman & Associates reported no remaining NRC Health Common Stock position as of Q2 2021 after selling out during the quarter.
  • Klingman & Associates sold 7,000 NRC Health Common Stock shares in Q2 2021, an estimated $328K.
  • Klingman & Associates first reported a position in NRC Health Common Stock in Q4 2020 and held it in 2 quarters.
  • Klingman & Associates's NRC Health Common Stock position peaked at $328K in Q1 2021.
  • 100 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2021.

Based on Klingman & Associates's 13F filing for Q2 2021, filed 27 Jul 2021.